Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that ...
The US FDA has approved Medtronic’s 780G for use with rapid-acting insulin and with Abbott’s type 2 diabetes-specific sensor.
FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.
With a design that prominently displays a bare needle, the Sen-Serter glucose sensor insertion device from Medtronic Diabetes (Northridge, CA) has been nicknamed "the harpoon" by diabetic bloggers.
Dexcom announced that its G7 diabetes sensor can now link directly to a user’s Apple Watch, allowing them to track their glucose readings in real-time even if their iPhone isn’t nearby. According to ...
Fully automated, ultra-high-volume line providing sub-second cycle time, medical-grade precision, and scalable capacity ...
Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc. (NASDAQ:TNDM) announced a new agreement with Abbott to develop and ...
These color-enhanced scanning electron microscope images show nanosheets resembling tiny rose petals. The nanosheets are key components of a new type of biosensor that can detect minute concentrations ...